New insights into why patients with cancer choose to go with recommendations from a second opinion rather than the initial advice. ( University of Colorado Anschutz Medical Campus )

Staffing cuts at the FDA could lead to major changes in the agency's accelerated approval process for oncology drugs. ( Clinical Trials Arena )

The SCREENS for Cancer Act reauthorization introduced in the Senate will ensure continued and improved access to prevention and early detection services for breast and cervical cancer, according to the American Cancer Society.

Online searches for information about cancer may leave searchers vulnerable to exploitative advertising. ( The Conversation )

Pharma giant Merck got at least a temporary win from the U.S. Patent and Trademark Office in a dispute

See Full Page